Trial Profile
Rates of nevirapine resistance in women receiving zidovudine and tenofovir/emtricitabine to prevent HIV-1 transmission from mother to child
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine/tenofovir; Zidovudine
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 20 Jun 2016 New trial record